247 related articles for article (PubMed ID: 19584973)
1. Amiodarone-induced thyrotoxicosis: a review.
Tsang W; Houlden RL
Can J Cardiol; 2009 Jul; 25(7):421-4. PubMed ID: 19584973
[TBL] [Abstract][Full Text] [Related]
2. Color-flow Doppler sonography in the differential diagnosis and management of amiodarone-induced thyrotoxicosis.
Loy M; Perra E; Melis A; Cianchetti ME; Piga M; Serra A; Pinna G; Mariotti S
Acta Radiol; 2007 Jul; 48(6):628-34. PubMed ID: 17611870
[TBL] [Abstract][Full Text] [Related]
3. Color flow Doppler sonography rapidly differentiates type I and type II amiodarone-induced thyrotoxicosis.
Bogazzi F; Bartalena L; Brogioni S; Mazzeo S; Vitti P; Burelli A; Bartolozzi C; Martino E
Thyroid; 1997 Aug; 7(4):541-5. PubMed ID: 9292940
[TBL] [Abstract][Full Text] [Related]
4. Thyroid color flow doppler sonography and radioiodine uptake in 55 consecutive patients with amiodarone-induced thyrotoxicosis.
Bogazzi F; Martino E; Dell'Unto E; Brogioni S; Cosci C; Aghini-Lombardi F; Ceccarelli C; Pinchera A; Bartalena L; Braverman LE
J Endocrinol Invest; 2003 Jul; 26(7):635-40. PubMed ID: 14594114
[TBL] [Abstract][Full Text] [Related]
5. Amiodarone-induced thyrotoxicosis. A review.
Piga M; Serra A; Boi F; Tanda ML; Martino E; Mariotti S
Minerva Endocrinol; 2008 Sep; 33(3):213-28. PubMed ID: 18846027
[TBL] [Abstract][Full Text] [Related]
6. Serum interleukin-6 in amiodarone-induced thyrotoxicosis.
Bartalena L; Grasso L; Brogioni S; Aghini-Lombardi F; Braverman LE; Martino E
J Clin Endocrinol Metab; 1994 Feb; 78(2):423-7. PubMed ID: 8106631
[TBL] [Abstract][Full Text] [Related]
7. Clinical characteristics of amiodarone-induced thyrotoxicosis and hypothyroidism in Japan.
Sato K; Miyakawa M; Eto M; Inaba T; Matsuda N; Shiga T; Ohnishi S; Kasanuki H
Endocr J; 1999 Jun; 46(3):443-51. PubMed ID: 10503998
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis and management of amiodarone-induced thyrotoxicosis in Europe: results of an international survey among members of the European Thyroid Association.
Bartalena L; Wiersinga WM; Tanda ML; Bogazzi F; Piantanida E; Lai A; Martino E
Clin Endocrinol (Oxf); 2004 Oct; 61(4):494-502. PubMed ID: 15473883
[TBL] [Abstract][Full Text] [Related]
9. Clinical experience of amiodarone-induced thyrotoxicosis over a 3-year period: role of colour-flow Doppler sonography.
Eaton SE; Euinton HA; Newman CM; Weetman AP; Bennet WM
Clin Endocrinol (Oxf); 2002 Jan; 56(1):33-8. PubMed ID: 11849244
[TBL] [Abstract][Full Text] [Related]
10. Management of amiodarone-induced thyrotoxicosis in Latin America: an electronic survey.
Diehl LA; Romaldini JH; Graf H; Bartalena L; Martino E; Albino CC; Wiersinga WM
Clin Endocrinol (Oxf); 2006 Oct; 65(4):433-8. PubMed ID: 16984234
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis and management of amiodarone-induced thyrotoxicosis: similarities and differences between North American and European thyroidologists.
Tanda ML; Piantanida E; Lai A; Liparulo L; Sassi L; Bogazzi F; Wiersinga WM; Braverman LE; Martino E; Bartalena L
Clin Endocrinol (Oxf); 2008 Nov; 69(5):812-8. PubMed ID: 18410546
[TBL] [Abstract][Full Text] [Related]
12. Radioactive iodine in the treatment of type-2 amiodarone-induced thyrotoxicosis.
Gursoy A; Tutuncu NB; Gencoglu A; Anil C; Demirer AN; Demirag NG
J Natl Med Assoc; 2008 Jun; 100(6):716-9. PubMed ID: 18595575
[TBL] [Abstract][Full Text] [Related]
13. Amiodarone-induced thyrotoxicosis in a patient with autonomously functioning nodular goiter.
Liang YL; Huang SM; Peng SL; Hsiao SH; Hung HC; Ou HY; Wu TJ
Ann Pharmacother; 2009 Jan; 43(1):134-8. PubMed ID: 19109209
[TBL] [Abstract][Full Text] [Related]
14. [Amiodarone and the thyroid gland].
Bednarek-Tupikowska G; Filus A; Kuliczkowska J; Bugajski J
Postepy Hig Med Dosw (Online); 2004 Apr; 58():216-25. PubMed ID: 15114257
[TBL] [Abstract][Full Text] [Related]
15. Approach to the patient with amiodarone-induced thyrotoxicosis.
Bogazzi F; Bartalena L; Martino E
J Clin Endocrinol Metab; 2010 Jun; 95(6):2529-35. PubMed ID: 20525904
[TBL] [Abstract][Full Text] [Related]
16. [Amiodarone-induced thyrotoxicosis].
Bogazzi F; Tomisti L; Di Bello V; Martino E
G Ital Cardiol (Rome); 2017 Mar; 18(3):219-229. PubMed ID: 28398380
[TBL] [Abstract][Full Text] [Related]
17. Identification of Two Different Phenotypes of Patients with Amiodarone-Induced Thyrotoxicosis and Positive Thyrotropin Receptor Antibody Tests.
Cappellani D; De Marco G; Ferrarini E; Torregrossa L; Di Certo AM; Cosentino G; Urbani C; Marconcini G; Mattiello A; Manetti L; Agretti P; Basolo F; Tonacchera M; Bartalena L; Bogazzi F
Thyroid; 2021 Oct; 31(10):1463-1471. PubMed ID: 34271828
[No Abstract] [Full Text] [Related]
18. Management of amiodarone-induced thyrotoxicosis.
Rajeswaran C; Shelton RJ; Gilbey SG
Swiss Med Wkly; 2003 Nov; 133(43-44):579-85. PubMed ID: 14745652
[TBL] [Abstract][Full Text] [Related]
19. [Challenges in the management of amiodarone-induced thyrotoxicosis].
Tauveron I; Batisse-Lignier M; Maqdasy S
Presse Med; 2018 Sep; 47(9):746-756. PubMed ID: 30274916
[TBL] [Abstract][Full Text] [Related]
20. Amiodarone and thyroid dysfunction.
Padmanabhan H
South Med J; 2010 Sep; 103(9):922-30. PubMed ID: 20689491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
